Fig. 5

Proportion of patients overall who reported improvements in psychosocial and quality-of-life domains (n = 253)^a,b. ^aFor time with family/friends, quality of time with family/friends, time at work/school, time participating in leisure activities, and enjoyment of leisure activities, patients responded to the following questions: “Compared to the 3-month baseline period before the first injection, on a scale of 0 to 10, where 0 is ‘significantly less’ and 10 is ‘significantly more,’…” “…how much less or more time did you spend with friends and family while you were taking the study medicine?” “…how much change did you experience in the quality of time you spent with your friends and family while you were taking the study medicine?” “…how much less or more were you able to attend work or school while you were taking the study medicine?” “…how much less or more could you participate in leisure and personal activities (i.e., hobbies) while you were taking the study medicine?” “…how much less or more were you able to enjoy leisure and personal activities while you were taking the study medicine?” ^bFor performance at work/school and performance of household activities, patients responded to the following questions: “Compared to the 3-month baseline period before the first injection, on a scale of 0 to 10, where 0 is ‘significantly worse’ and 10 is ‘significantly better,’…” “…how did your work or school performance change while you were taking the study medicine?” “…how much did your ability to perform household activities and chores change while you were taking the study medicine?” ^cn = 213